Rating Change
Evercore ISI Group reiterated its Outperform rating on Travere Therapeutics, Inc. (NASDAQ:TVTX) on August 10, 2026.
reiterateNASDAQ:TVTX
Evercore ISI Group Reiterates Outperform Rating on Travere Therapeutics, Inc. (TVTX)
Evercore ISI Group reiterated its Outperform rating on Travere Therapeutics, Inc. (NASDAQ:TVTX) on August 10, 2026.
At publication ·
What changed
Travere Therapeutics, Inc. (NASDAQ:TVTX) · reiterate
- Firm
- Evercore ISI Group
- Rating
- Outperform to Outperform
- Price at event
- $60.89
- Market capitalization
- $3.1B
At a glance
Key takeaways
- Evercore ISI Group reiterated an Outperform rating on Travere Therapeutics (TVTX) on August 10, 2026, with the stock trading at $60.89 and a market capitalization of $3.1 billion.
Market Context
Travere Therapeutics, Inc. operates in the Healthcare sector. The stock currently trades at $60.89 with a market capitalization of $3.1B. The stock has gained 260.1% over the past 52 weeks.
Analyst coverage from Evercore ISI Group provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Travere Therapeutics, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Travere Therapeutics, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 10, 2026 | Evercore ISI Group | Outperform | N/A |
| Aug 06, 2026 | Wedbush | Outperform | N/A |
| Aug 06, 2026 | Canaccord Genuity | Buy | N/A |
| Aug 05, 2026 | Evercore ISI Group | Outperform | N/A |
| Aug 05, 2026 | Citigroup | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View TVTX Stock Page
Frequently Asked Questions
What does the Outperform rating mean for TVTX?
A rating of Outperform from Evercore ISI Group reflects the analyst's outlook on Travere Therapeutics, Inc. (NASDAQ:TVTX). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the TVTX forecast page.